| Size & multiples | |||
| Market Cap | $818.6M | Enterprise Value | — |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 1.96× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | — | EV/FCF | — |
| FCF Yield | −2.24% | Buyback Yield | — |
| Owner Earnings (TTM) | -$7.4M | Owner Earnings Yield | −0.91% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.10 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 9.51% |
| After-tax Cost of Debt | — | Synthetic credit rating | CC |
| Cost of Debt · embedded (pre-tax) | — | Cost of Debt · marginal (synthetic) | 16.61% |
| WACC | — | ROIC | — |
| EVA Spread (ROIC−WACC) | — | EVA | — |
FCF sits 148% below owner earnings — spending above maintenance (growth capex) or absorbing working capital, so FCF understates the steady-state cash the business throws off.
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM -$0.11 · revenue TTM $418.2M · FCF TTM -$18.4M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -1.6% | -7.8% | -34.7%–1.4% | 65 ↑strong |
| Net Margin | -5.6% | -21.2% | -325.3%–7.2% | 60 ↑strong |
| Operating Margin | 15.0% | -34.5% | -552.0%–8.0% | 85 ↑strong |
